(((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)methyl)phosphonic acid, x sodium salt

Catalog No. :
ACLZUS605
CAS No. :
89016-30-8
Molecular Formula :
C11H15N5Na2O9P2
Molecular Weight :
448.22

IUPAC Name:(((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)methyl)phosphonic acid, x sodium salt

(((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)methyl)phosphonic acid, x sodium salt structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)methyl)phosphonic acid, x sodium salt
IUPAC Name(((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)methyl)phosphonic acid, x sodium salt
Molecular FormulaC11H15N5Na2O9P2
Molecular Weight448.22
SMILESO=P(CP([O-])([O-])=O)(OC[C@H]1O[C@@H](N2C=NC3=C(N)N=CN=C23)[C@H](O)[C@@H]1O)O.[Na+].[Na+]
InChI KeyRFGZKSPLJPHQMI-YCSZXMBFSA-M
SynonymAMPCP, APCP | α,β-Methyleneadenosine 5'-diphosphate monosodium salt
CAS No.89016-30-8
PubChem CID91691113

Synthetic Route by SureRoute

1. ACLZUS605 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLZUS605 route product structure diagram
    ACLZUS60589016-30-8
Inquiry

2. ACLZUS605 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLZUS605 route product structure diagram
    ACLZUS60589016-30-8
Inquiry

Comments (0)